Influence of NAT2 Polymorphisms on Sulfamethoxazole Pharmacokinetics in Renal Transplant Recipients

Por Kagaya, Hideaki, Miura, Masatomo, Niioka, Takenori, Saito, Mitsuru, Numakura, Kazuyuki, Habuchi, Tomonori, Satoh, Shigeru
Publicado em 2012

Enantioselective disposition of rabeprazole in relation to CYP2C19 genotypes

Por Miura, Masatomo, Kagaya, Hideaki, Tada, Hitoshi, Uno, Tsukasa, Yasui-Furukori, Norio, Tateishi, Tomonori, Suzuki, Toshio
Publicado em 2006

Capability of Utilizing CYP3A5 Polymorphisms to Predict Therapeutic Dosage of Tacrolimus at Early Stage Post-Renal Transplantation

Por Niioka, Takenori, Kagaya, Hideaki, Saito, Mitsuru, Inoue, Takamitsu, Numakura, Kazuyuki, Habuchi, Tomonori, Satoh, Shigeru, Miura, Masatomo
Publicado no Int J Mol Sci (2015)

Prediction of Tacrolimus Exposure by CYP3A5 Genotype and Exposure of Co-Administered Everolimus in Japanese Renal Transplant Recipients

Por Kagaya, Hideaki, Niioka, Takenori, Saito, Mitsuru, Inoue, Takamitsu, Numakura, Kazuyuki, Yamamoto, Ryohei, Akamine, Yumiko, Habuchi, Tomonori, Satoh, Shigeru, Miura, Masatomo
Publicado no Int J Mol Sci (2018)

Lack of tacrolimus circadian pharmacokinetics and CYP3A5 pharmacogenetics in the early and maintenance stages in Japanese renal transplant recipients

Por Satoh, Shigeru, Kagaya, Hideaki, Saito, Mitsuru, Inoue, Takamitsu, Miura, Masatomo, Inoue, Kazuyuki, Numakura, Kazuyuki, Tsuchiya, Norihiko, Tada, Hitoshi, Suzuki, Toshio, Habuchi, Tomonori
Publicado em 2008

Characterization of Clinical and Genetic Risk Factors Associated with Dyslipidemia after Kidney Transplantation

Por Numakura, Kazuyuki, Kagaya, Hideaki, Yamamoto, Ryohei, Komine, Naoki, Saito, Mitsuru, Hiroshi, Tsuruta, Akihama, Susumu, Inoue, Takamitsu, Narita, Shintaro, Tsuchiya, Norihiko, Habuchi, Tomonori, Niioka, Takenori, Miura, Masatomo, Satoh, Shigeru
Publicado no Dis Markers (2015)